Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, 12 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Proof Of Concept Study Evaluating The Efficacy And Safety Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis/Painful Bladder Syndrome.

NCT00739739 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00739739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00739739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, 12 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Proof Of Concept Study Evaluating The Efficacy And Safety Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis/Painful Bladder Syndrome.
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2008
Completion date
January 31, 2010
Enrollment
161 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis, painful bladder syndrome